Finally, targeting Trpv3 via PVLP delivery of SaCas9 or shRNA was remarkably efficient in primary keratinocytes and resulted in rescue of Olmsted syndrome phenotypes in ex vivo mouse skin equivalents. This evidence concerns the gene TRPV3 and Olmsted syndrome.